Patients with pathogenic variants in MSH6 are mostly diagnosed with CRC at older ages [24], but MSH6 germline variants were described in six out of eleven early onset CRC patients with PGV in the MMR genes in the Spanish cohort mentioned above [8]. This evidence concerns the gene MSH6 and colorectal carcinoma.